Actualités Spectral AI Inc - MDAI | Actions NASDAQ

Spectral AI Comments on Compliance with Nasdaq Listing Rule 5550(b)(2)

DALLAS, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”...

Spectral AI Highlights Unprecedented Collaboration with National Leaders in Burn Care for DeepView™ System Training and Validation Studies

DALLAS, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”...

Spectral AI Incorporates Frontline Feedback into Improved Software Release for Enhanced Diagnostic Precision

DALLAS, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), an...

Spectral AI Completes Truthing of Burn Center Images, Initiates Emergency Department Image Review

DALLAS, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), an...

Spectral AI Announces Repricing of its Public Warrants

DALLAS, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), an...

Spectral AI Announces DeepView SnapShot® M Moves Forward with Feedback from Brooke Army Medical Center Institute of Surgical Research

DALLAS, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (Spectral AI or the Company), an...

Spectral AI Raises Up to $5 Million Financing Strengthening Financial Position for FDA Pathway

DALLAS, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”...

Spectral AI Announces 2024 Third Quarter Financial Results

Revenue Rose to $8.2 MillionCompany Reaffirms Timeline for Regulatory Submission to U.S. FDA Q3 2024 Overview...

Spectral AI Announces Plan to Spin Off Spectral IP Subsidiary Focused on Intellectual Property Investments and Monetization

DALLAS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”...

Spectral AI Announces Last Patient Out in U.S. Burn Pivotal Study at Burn Centers

Milestone Achievement Supports Planned FDA Submission of DeepView AI®-Burn in 2025 DALLAS, Oct. 30, 2024...

Spectral AI Schedules 2024 Third Quarter Financial Results and Conference Call

DALLAS, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”...

Spectral AI, Inc. Announces Return of Founder Dr. J. Michael DiMaio as Chairman of the Board of Directors

DALLAS, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”...

Spectral AI Completes Proof of Concept for Wound Measurement Technology

DALLAS, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”...

Spectral AI Achieves 25% Patient Enrollment at Emergency Departments for U.S. Burn Pivotal Study and Adds Two New Clinical Trial Sites

DALLAS, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”...

Spectral AI Outlines U.S. Regulatory Pathway for DeepView® System for Burn Indication

DALLAS, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Spectral AI Inc (MDAI)

Votre Hub pour des idées et discussions en direct en temps réel

MDAI Actualités

Spectral AI Comments on Compliance with Nasdaq Listing Rule 5550(b)(2)

Spectral AI Highlights Unprecedented Collaboration with National Leaders in Burn Care for DeepView™ System Training and Validation Studies

Spectral AI Incorporates Frontline Feedback into Improved Software Release for Enhanced Diagnostic Precision

Spectral AI Completes Truthing of Burn Center Images, Initiates Emergency Department Image Review

Spectral AI Announces Repricing of its Public Warrants

Spectral AI Announces DeepView SnapShot® M Moves Forward with Feedback from Brooke Army Medical Center Institute of Surgical Research

Spectral AI Raises Up to $5 Million Financing Strengthening Financial Position for FDA Pathway

Spectral AI Announces 2024 Third Quarter Financial Results

Spectral AI Announces Plan to Spin Off Spectral IP Subsidiary Focused on Intellectual Property Investments and Monetization

Spectral AI Announces Last Patient Out in U.S. Burn Pivotal Study at Burn Centers

Spectral AI Schedules 2024 Third Quarter Financial Results and Conference Call

Spectral AI, Inc. Announces Return of Founder Dr. J. Michael DiMaio as Chairman of the Board of Directors

Spectral AI Completes Proof of Concept for Wound Measurement Technology

Spectral AI Achieves 25% Patient Enrollment at Emergency Departments for U.S. Burn Pivotal Study and Adds Two New Clinical Trial Sites

Spectral AI Outlines U.S. Regulatory Pathway for DeepView® System for Burn Indication

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Spectral AI Inc (MDAI) Actualités

Spectral AI Inc (MDAI)

Votre Hub pour des idées et discussions en direct en temps réel

MDAI Actualités

Spectral AI Comments on Compliance with Nasdaq Listing Rule 5550(b)(2)

Spectral AI Highlights Unprecedented Collaboration with National Leaders in Burn Care for DeepView™ System Training and Validation Studies

Spectral AI Incorporates Frontline Feedback into Improved Software Release for Enhanced Diagnostic Precision

Spectral AI Completes Truthing of Burn Center Images, Initiates Emergency Department Image Review

Spectral AI Announces Repricing of its Public Warrants

Spectral AI Announces DeepView SnapShot® M Moves Forward with Feedback from Brooke Army Medical Center Institute of Surgical Research

Spectral AI Raises Up to $5 Million Financing Strengthening Financial Position for FDA Pathway

Spectral AI Announces 2024 Third Quarter Financial Results

Spectral AI Announces Plan to Spin Off Spectral IP Subsidiary Focused on Intellectual Property Investments and Monetization

Spectral AI Announces Last Patient Out in U.S. Burn Pivotal Study at Burn Centers

Spectral AI Schedules 2024 Third Quarter Financial Results and Conference Call

Spectral AI, Inc. Announces Return of Founder Dr. J. Michael DiMaio as Chairman of the Board of Directors

Spectral AI Completes Proof of Concept for Wound Measurement Technology

Spectral AI Achieves 25% Patient Enrollment at Emergency Departments for U.S. Burn Pivotal Study and Adds Two New Clinical Trial Sites

Spectral AI Outlines U.S. Regulatory Pathway for DeepView® System for Burn Indication

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application